Treatment schedules influence acquisition of Doxorubicin resistance through epigenetic mechanism in breast cancer cells.

Singh, K. (Speaker)

Activity: Talk or presentationOther

PeriodApr 1 2017Apr 30 2017
Held atAmerican Association of Cancer Research
Degree of RecognitionInternational